Segall Bryant & Hamill LLC Cuts Stock Position in Mirion Technologies, Inc. $MIR

Segall Bryant & Hamill LLC lessened its holdings in Mirion Technologies, Inc. (NYSE:MIR) by 4.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,111,874 shares of the company’s stock after selling 57,815 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Mirion Technologies were worth $20,670,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Stephens Investment Management Group LLC purchased a new stake in Mirion Technologies during the fourth quarter worth about $18,969,000. UBS Group AG raised its position in Mirion Technologies by 1.2% in the fourth quarter. UBS Group AG now owns 4,852,587 shares of the company’s stock worth $113,648,000 after acquiring an additional 55,754 shares during the period. Tredje AP fonden bought a new stake in Mirion Technologies in the fourth quarter worth about $6,576,000. Allspring Global Investments Holdings LLC boosted its stake in Mirion Technologies by 81.5% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,030,230 shares of the company’s stock valued at $24,550,000 after acquiring an additional 462,643 shares during the last quarter. Finally, First National Advisers LLC purchased a new position in Mirion Technologies in the fourth quarter valued at about $2,604,000. 78.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MIR has been the subject of several research analyst reports. Weiss Ratings lowered shares of Mirion Technologies from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, July 20th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $23.00 price target on shares of Mirion Technologies in a report on Wednesday. Citigroup dropped their price objective on Mirion Technologies from $28.00 to $24.00 and set a “buy” rating on the stock in a research note on Thursday. B. Riley Financial reduced their price objective on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a report on Thursday. Finally, Morgan Stanley decreased their target price on Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating for the company in a research report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $26.25.

Insiders Place Their Bets

In other Mirion Technologies news, CAO Christopher A. Moore sold 8,400 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $19.64, for a total transaction of $164,976.00. Following the sale, the chief accounting officer owned 22,157 shares of the company’s stock, valued at $435,163.48. The trade was a 27.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 6.30% of the company’s stock.

Mirion Technologies Price Performance

Shares of NYSE:MIR opened at $14.99 on Friday. The firm has a market capitalization of $3.75 billion, a PE ratio of 149.89 and a beta of 1.03. The company has a quick ratio of 2.63, a current ratio of 3.20 and a debt-to-equity ratio of 0.64. The company has a 50-day moving average price of $17.09 and a two-hundred day moving average price of $19.72. Mirion Technologies, Inc. has a twelve month low of $14.11 and a twelve month high of $30.28.

Mirion Technologies (NYSE:MIR) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.02. The company had revenue of $266.80 million for the quarter, compared to analyst estimates of $269.32 million. Mirion Technologies had a net margin of 2.39% and a return on equity of 6.59%. The company’s quarterly revenue was up 19.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.11 earnings per share. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. Equities analysts forecast that Mirion Technologies, Inc. will post 0.54 EPS for the current year.

Key Stories Impacting Mirion Technologies

Here are the key news stories impacting Mirion Technologies this week:

• Positive Sentiment: Mirion maintained its 2026 outlook and expects second-half organic revenue growth of approximately 7.5% to 11.2%, alongside adjusted EBITDA margins of 27% to 29%. This indicates management still expects solid underlying growth and profitability improvement. Mirion maintains 2026 outlook
• Positive Sentiment: Citigroup lowered its price target to $24 from $28 but retained a “buy” rating, implying substantial upside from the current trading level. B. Riley likewise maintained a “buy” rating while reducing its target to $27 from $29. Citigroup price target update
• Neutral Sentiment: Mirion’s latest quarterly results showed adjusted earnings of $0.12 per share, ahead of the $0.10 consensus estimate, while revenue rose 19.7% year over year to $266.8 million but fell slightly short of expectations. The mixed results highlight strong growth but limited near-term execution upside. Mirion Q2 2026 earnings call summary
• Negative Sentiment: Northland Securities reduced its Q3 2026 EPS estimate to $0.12 from $0.14 and lowered its FY2027 forecast to $0.71 from $0.72. Although the cuts are modest, they signal softer expectations for near-term earnings growth and may contribute to selling pressure.

Mirion Technologies Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.